Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term

被引:0
|
作者
Liqi Chen
Guoli Li
Jieshou Li
Chaogang Fan
Jian Xu
Bo Wu
Kun Liu
Caihua Zhang
机构
[1] Medical School of Nanjing University,Department of Surgery, Jinling Hospital
[2] Medical School of Nanjing University,Department of Medical Imaging, Jinling Hospital
[3] Medical School of Nanjing University,Department of Pathology, Jinling Hospital
[4] Gastrointestinal Surgery of Xuzhou Central Hospital,undefined
来源
关键词
Gastric cancer; Preoperative chemotherapy; ERCC1; TS; Endarterial-intravenous coadministration; Real-time Fluorescent quantitative PCR;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:921 / 928
页数:7
相关论文
共 50 条
  • [41] Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
    Baba, H.
    Watanabe, M.
    Okabe, H.
    Miyamoto, Y.
    Sakamoto, Y.
    Baba, Y.
    Iwatsuki, M.
    Chikamoto, A.
    Beppu, T.
    BRITISH JOURNAL OF CANCER, 2012, 107 (12) : 1950 - 1955
  • [42] Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer
    Liu, Jia
    Zhang, Lin
    Mao, Ping
    Jiang, Guoqiang
    Liu, Likun
    Wang, Jing
    Yang, Wei
    Owusu, Lawrence
    Li, Weiling
    ONCOTARGET, 2017, 8 (49) : 85759 - 85771
  • [43] Correlation of ERCC1 mRNA expression with KRAS mutation status in colorectal, pancreatic, and lung adenocarcinoma
    Hanna, Diana L.
    Maus, Martin K. H.
    Stephens, Craig
    Grimminger, Peter Philipp
    Astrow, Stephanie H.
    Yang, Dongyun
    Loupakis, Fotios
    Hsiang, Jack
    Zeger, Gary
    Barzi, Afsaneh
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer
    He, M. G.
    Zheng, K.
    Tan, D.
    Wang, Z. X.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (01): : 1 - 7
  • [45] TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials
    P P Grimminger
    M Shi
    C Barrett
    D Lebwohl
    K D Danenberg
    J Brabender
    C L P Vigen
    P V Danenberg
    T Winder
    H-J Lenz
    The Pharmacogenomics Journal, 2012, 12 : 404 - 411
  • [46] ERCC1 mRNA Expression as a Postoperative Prognostic Marker in Extrahepatic Bile Duct Cancer
    Shuichiro Uemura
    Hidekazu Kuramochi
    Ryota Higuchi
    Go Nakajima
    Masakazu Yamamoto
    Annals of Surgical Oncology, 2014, 21 : 627 - 633
  • [47] Association between ERCC1 and XPF polymorphisms and risk of colorectal cancer
    Yang, H.
    Li, G.
    Li, W. F.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 700 - 705
  • [48] ERCC1 mRNA Expression as a Postoperative Prognostic Marker in Extrahepatic Bile Duct Cancer
    Uemura, Shuichiro
    Kuramochi, Hidekazu
    Higuchi, Ryota
    Nakajima, Go
    Yamamoto, Masakazu
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S627 - S633
  • [49] Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma
    Cao, Z. H.
    Yin, H. P.
    Jiang, N.
    Yu, B.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 10145 - 10151
  • [50] Effect of Peimine on ERCC1 mRNA and LRP expressions of A549 / DDP multidrug resistance cell line
    唐晓勇
    China Medical Abstracts(Internal Medicine), 2016, 33 (01) : 8 - 9